Letizia Consoli

ORCID: 0000-0001-6954-6114
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Paraoxonase enzyme and polymorphisms
  • Hormonal Regulation and Hypertension
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Ultrasound in Clinical Applications
  • COVID-19 diagnosis using AI
  • COVID-19 Clinical Research Studies
  • Electrolyte and hormonal disorders
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Hibiscus Plant Research Studies
  • Eicosanoids and Hypertension Pharmacology
  • Gout, Hyperuricemia, Uric Acid
  • Pharmacogenetics and Drug Metabolism
  • Urinary Bladder and Prostate Research
  • Adrenal Hormones and Disorders
  • Cardiac Valve Diseases and Treatments
  • Long-Term Effects of COVID-19
  • Blood Coagulation and Thrombosis Mechanisms
  • Fatty Acid Research and Health
  • Chronic Myeloid Leukemia Treatments
  • Nutrition, Genetics, and Disease
  • Eosinophilic Disorders and Syndromes

Universidade Federal da Bahia
2025

Fondazione Poliambulanza Istituto Ospedaliero
2020-2022

Agostino Gemelli University Polyclinic
2020

Istituti di Ricovero e Cura a Carattere Scientifico
2020

University of Verona
2009-2013

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2005

Low concentrations of plasma high-density lipoprotein (HDLs) are characteristic in metabolic syndrome (MS). The antioxidant ability HDLs is, at least part, attributable to pleiotropic serum paraoxonase (PON1). Different PON1 activities have been assessed 293 subjects with (n = 88) or without MS 205) and 195) 98) angiographically proven coronary artery disease (CAD). had low activities, a progressively decreasing trend by increasing the number abnormalities. activity versus 7-O-diethyl...

10.1155/2012/231502 article EN Experimental Diabetes Research 2011-09-22

A key issue in abdominal US is the assessment of fluid, which usually anechoic, thus appearing "black". Our approach focuses on searching for fluid non-traumatic patients, providing a new, simplified method point-of-care (POCUS).Fluid based three-step analysis that we can summarize. 1. Look black where it should not be. This means effusions or collections. 2. Check if too much. evaluating anatomical landmarks normally be present but may abnormally abundant. 3. clearly black. aspects, whether...

10.3390/tomography8020066 article EN cc-by Tomography 2022-03-15

In December 2019, a novel coronavirus (SARS-Cov-2) was first reported in Wuhan, China, and rapidly spread around the world, leading to an international emerging public health emergency. As from Chinese experiences, approximately 20% of patients had severe course, requiring intensive care, with overall case fatality rate 2.3%. diagnosis, chest computed tomography most commonly showed ground-glass opacity or without consolidative patterns. Herein, we report patient affected by COVID-19...

10.1007/s40477-020-00494-3 article EN other-oa Journal of Ultrasound 2020-06-19

Background: A reduced activity of the 11 beta-hydroxysteroid dehydrogenase 2 (11 beta-HSD2) causes hypertension by conferring aldosterone selectivity to mineralcorticoid receptors and eventually impairing tetrahydrocortisol-versus tetrahydrocortisone-metabolites (THFs/THE) shuttle. The beta-HSD2 function is modulated glucocorticoid treatment that may induce through a mechanism mostly unknown. Promoter methylation, one main epigenetic potentially modifiable feature DNA, regulates HSD11B2 gene...

10.21767/2472-1158.100012 article EN Journal of Clinical Epigenetics 2016-01-01

Chiecchi, L.1; Pizzolo, F.1; Kitamura, K.2; Raffaelli, R.1; Consoli, Gunasekaran, M.1; Castagna, A.1; Salvagno, G.1; Guarini, P.1; Olivieri, O.1 Author Information

10.1097/00004872-201106001-01553 article EN Journal of Hypertension 2011-06-01
Coming Soon ...